Surveillance and treatment are two different things.
I will say on the surveillance side—and it's no secret that we and colleagues here refer to it—we don't have a terrific system of surveillance at the national level. The development of surveillance systems, I think, is variable across the country. In places like B.C. it's excellent, in other places, it's not quite there. That is something we're working on. That's what I would say on surveillance.
On treatment, I think it's always been recognized that treatment is incredibly important. There was a significant investment into treatment in the 2014 budget coming out of the work of this committee and the work that Rita had referred to earlier on in “First Do No Harm”. There is certainly more that can be done both in terms of work on medication-assisted therapy but also treatment indicators, work on first nations. I'd say that is continuing to be a focus of ours.